Dr Robert DeBernardo explains how new immunotherapies are reshaping care and how their earlier availability might have ...

Trials in AF and acute coronary syndrome were stopped early for futility, but there’s hope for factor XIa inhibitors given ...

Nasal vaccines offer convenience and another option for those wary of needles, but traditional vaccines are best for young ...

NHS Scotland has approved a one-time CRISPR gene therapy for severe sickle cell disease, offering durable reduction in ...

A 70-year-old Black woman who had irreversible chronic heart disease — and more seriously than that, end-stage renal disease ...

Different from hospice or palliative care, end-of-life doulas help shepherd patients and loved ones through the process of ...

Your patient may be doing everything right but still not making progress. But there’s more to it than just A1c.

Elevated baseline LDH levels predict worse clinical outcomes in heart failure with reduced ejection fraction and modestly ...

Dulaglutide, a long-acting GLP-1 receptor agonist, can suppress copeptin levels in individuals with euvolaemia, a secondary ...

“High-sensitivity CRP has been shown to be an independent marker of risk in addition to and in some cases over and above all ...

Autopsy reveals man dies from sepsis after aluminium eyeliner, inserted autoerotically, penetrates rectum and forms giant ...

Having a relative with a congenital heart defect is tied to increased odds of being affected, with a stronger influence from ...